99mTc-PSMA Scintigraphy in Splenic Hemangioma.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2025-05-12 DOI:10.1097/RLU.0000000000005969

Ahmad Ghasemifard, Amin Saber Tanha, Faeze Rabani, Amir Behforouz, Emran Askari

引用次数: 0

Abstract

A 67-year-old man was referred for initial staging of prostate adenocarcinoma (Gleason score 4+3, 7/12 cores positive). A 99mTc-PSMA scintigraphy revealed localized uptake in the right prostate lobe (miTNM: T2mN0M0, and PRIMARY score: 5) and increased uptake in a hypo-dense splenic lesion (PSMA-RADS-3C), which was subsequently confirmed as a hemangioma on further evaluations. This case underscores the potential for false-positive 99mTc-PSMA uptake in splenic hemangiomas, highlighting the importance of considering this possibility in clinical practice.

查看原文本刊更多论文

脾血管瘤的99mTc-PSMA显像。

一名67岁男性因前列腺腺癌的初始分期（Gleason评分4+3,7/12核阳性）被转诊。99mTc-PSMA显像显示右前列腺叶局部摄取（miTNM: T2mN0M0， PRIMARY评分：5），低密度脾病变（psma - rad - 3c）摄取增加，随后进一步评估证实为血管瘤。本病例强调了在脾血管瘤中99mTc-PSMA摄取假阳性的可能性，强调了在临床实践中考虑这种可能性的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.